Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Compass Health Brands (Corporate Office)
EIR
•Compass Health Brands (Corporate Office)•October 7, 2021

Compass Health Brands (Corporate Office) – FDA EIR, Oct 7, 2021

Record Details

An FDA inspection of Compass Health Brands Corp., a medical device initial importer, complaint handling unit, and distributor, was conducted from September 16 to October 7, 2021. The inspection, initiated as a follow-up to a Class I recall, focused on compliance with medical device regulations (per compliance program 7382.845). At the inspection's conclusion, an FDA-483 was issued to the company's President and CEO, Stuart J. Straus, detailing several significant observations. Main violations included the late reporting of a Class I correction and removal to the FDA (21 CFR 806.10(b)) and inadequate corrective and preventive action (CAPA) activities (21 CFR 820.100(b)). Specifically, the firm's corrective actions for adjustable bath seats involved in serious injuries were found insufficient, and supplier corrective actions for overheating devices were not adequately managed. The inspection also identified incomplete risk analyses (21 CFR 820.30(g)) and a lack of established design change procedures (21 CFR 820.30(i)) for Class II devices where the company holds 510(k)s. Furthermore, inadequate control over supplier changes to specifications (21 CFR 820.50), with approvals occurring after implementation and conflicting documentation, was cited. A verbal observation was also made regarding the incomplete information provided to foreign manufacturers for medical device reporting. All observations were met with a commitment to correct by the CEO.

Company
Compass Health Brands (Corporate Office)
Inspection date
October 7, 2021
Product type
devices
Office
Chicago District Office
Person
  • Benjamin J. Dastoli (Investigator )
View Company Profile

ID · dea1bf8d-d071-440f-af90-21bb85af5e44

Violation Codes10
21 CFR 820.50(a)21 CFR 820.50(a)(1)21 CFR 820.19821 CFR 820.3021 CFR 820.30(i)21 CFR 820.100(b)21 CFR 806.10(b)21 CFR 80321 CFR 820.5021 CFR 820.30(g)

Full citation text and observation details available on the Dashboard.

Other documents for Compass Health Brands (Corporate Office)
  • 483 - 2022-12-19December 19, 2022
  • 483 - 2021-10-07October 7, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Compass Health Brands (Corporate Office)
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.